TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial

BACKGROUND: Cervical dysplasia (cervical intraepithelial neoplasia (CIN)) is caused by Human Papillomavirus (HPV) and is most common in women of reproductive age. Current treatment of moderate to severe CIN is surgical. This procedure has potential complications, such as haemorrhage, infection and p...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Sande, A. J. M., Koeneman, M. M., Gerestein, C. G., Kruse, A. J., van Kemenade, F. J., van Beekhuizen, H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003116/
https://www.ncbi.nlm.nih.gov/pubmed/29902979
http://dx.doi.org/10.1186/s12885-018-4510-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003116/
https://www.ncbi.nlm.nih.gov/pubmed/29902979
http://dx.doi.org/10.1186/s12885-018-4510-7

Ejemplares similares